Reporter Sept 9 2022

September 13, 2022

Cancer registries and sarcoma research

The number of sarcoma research studies that use the two largest U.S. cancer registries is increasing, but over one-third of studies that asked the same research question reported conflicting findings.

By Leigh MacMillan
September 12, 2022

Enhancing innate immunity in the lung

Vanderbilt researchers show that a TLR4 agonist improves lung immune response and survival in a mouse model of bacterial pneumonia, supporting the development of this drug to protect against pneumonia in hospitalized patients.

By Leigh MacMillan
September 8, 2022

PheWAS reveals post-COVID-19 diagnoses

Using a high-throughput informatics technique and electronic health records, Vanderbilt researchers found that COVID-19 survivors had an increased risk for more than 40 new diagnoses.

By Bill Snyder
September 8, 2022

Simple Beginnings

Vanderbilt held its annual Simple Beginnings ceremony for new doctoral students last week in Light Hall.

By VUMC News and Communications
September 8, 2022

Diabetes research grant receives NIDDK renewal

The Vanderbilt Diabetes Research and Training Center is celebrating its 49th year of continual operation with the five-year competitive renewal of a $10.9 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health.

By Jill Clendening
September 8, 2022

Calkins lands national award for research on blinding eye diseases

Vanderbilt’s David Calkins, PhD, has been selected by the Research to Prevent Blindness and Association of University Professors of Ophthalmology to receive the 2023 David F. Weeks Award for Outstanding Vision Research.

By Nancy Humphrey
September 8, 2022

Family’s gift supports efforts of three pediatric clinicians

The family of the late William (Bill) Long, MD, made a gift to establish the Dr. William R. Long Fund to support directorships, resident education, fellowships and psychologists in the Department of Pediatrics at Vanderbilt University Medical Center.
By Nancy Humphrey
September 8, 2022

Immune cells drive beta cell loss in Type 2 diabetes

Vanderbilt researchers have discovered details of pancreatic beta cell loss — and potential therapeutic targets — during conditions of overnutrition, as occurs in obesity.
By Kelsey Pinckard
September 8, 2022

Study tests drug to illuminate cancer during surgery

A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.
By Craig Boerner
September 8, 2022

Patient capacity command center created

Vanderbilt has created a command center charged with identifying and eliminating capacity constraints throughout the health system that could limit the ability to consistently serve all patients in a timely and equitable manner.
By John Howser
September 8, 2022

Transplant docuseries lauded by Donate Life Hollywood

“Last Chance Transplant,” the docuseries filmed at Vanderbilt in conjunction with 44 Blue Productions and Rock’n Robins Productions, received the 2022 Inspire Award on Thursday, Aug. 25, from Donate Life Hollywood.
By Kylie Avery
September 8, 2022

Juárez named director of behavior analysis

Pablo Juárez, MEd, BCBA, LBA, has been named director of behavior analysis within the Vanderbilt Kennedy Center and the Division of Developmental Medicine at Vanderbilt University Medical Center.
By Courtney Taylor
September 7, 2022

VUMC study will evaluate alternative strategies for administering mpox vaccine

Rarely fatal, the mpox virus — spread by close, often skin-to-skin contact — causes a painful, blistering rash, fever, chills and other symptoms.
By Bill Snyder
1 2